Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty.
Lee
Cheol Whan
CW
Department of Medicine, Asan Medical Center, University of Ulsan, Seoul, South Korea.
Moon
Dae-Hyuk
DH
Hong
Myeong-K i
MK
Lee
Jae-Hwan
JH
Choi
S i-Wan
Si
Yang
Hyun Suk
HS
Kim
Jae-Joong
JJ
Park
Seong-Wook
SW
Park
Seung-Jung
SJ
D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab